Literature DB >> 350350

Dopamine uptake in serotoninergic terminals in vitro: a valuable tool for the histochemical differentiation of catecholaminergic and serotoninergic terminals in rat cerebral structures.

B Berger, J Glowinski.   

Abstract

An in vitro method was developed to separately visualize dopaminergic, noradrenergic and serotoninergic terminals in the cerebral, hippocampal and cerebellar cortices of the rat, by means of the glyoxylic histochemical fluorescence method. Animals were pretreated with alpha-methylparatyrosine to deplete catecholamine stores. Thin vibratome sections were made and incubated in the presence of various exogenous amines and inhibitors of the catecholaminergic and serotoninergic transport systems. Experimental conditions insuring the best specificity were determined and the validity of the combined pharmacological and histochemical approach was further tested by using animals in which the cortical dopaminergic, noradrenergic or serotoninergic innervations were destroyed. Under the experimental conditions used, norepinephrine as well as alpha-methyl-norepinephrine were taken up in only noradrenergic and dopaminergic terminals. A separate visualization of the two systems was obtained by using specific uptake inhibitors. Dopamine was taken up not only in catecholaminergic but also in serotominergic terminals. The uptake of DA in serotoninergic fibers was inhibited by a specific inhibitor of the serotoninergic transport system or by the presence of serotonine in the incubating medium. The signification and the implications of thes results are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350350     DOI: 10.1016/0006-8993(78)90770-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

2.  Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area.

Authors:  K Ornstein; H Milon; A McRae-Degueurce; C Alvarez; B Berger; H P Würzner
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 3.  Chronic cobalt-induced epilepsy: noradrenaline ionophoresis and adrenoceptor binding studies in the rat cerebral cortex.

Authors:  B Bregman; F Le Saux; S Trottier; P Chauvel; Y Maurin
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Effect of noradrenalin on growth and differentiation of explanted rat hippocampal cells.

Authors:  E I Chumasov; A R Chubakov; G V Konovalov; E A Gromova
Journal:  Neurosci Behav Physiol       Date:  1984 Jan-Feb

5.  Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

Authors:  Mads Breum Larsen; Mark S Sonders; Ole Valente Mortensen; Gaynor A Larson; Nancy R Zahniser; Susan G Amara
Journal:  J Neurosci       Date:  2011-04-27       Impact factor: 6.167

6.  Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.

Authors:  O Cases; C Lebrand; B Giros; T Vitalis; E De Maeyer; M G Caron; D J Price; P Gaspar; I Seif
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

7.  In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells.

Authors:  A Prochiantz; U di Porzio; A Kato; B Berger; J Glowinski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.

Authors:  T J Feuerstein; G Hertting; A Lupp; B Neufang
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

Review 9.  The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972

10.  Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro.

Authors:  L M Hemmendinger; B B Garber; P C Hoffmann; A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.